Literature DB >> 27134604

Optimizing the Use of Biologic Therapies in the Management of Inflammatory Bowel Disease.

Gerald W Dryden1.   

Abstract

Entities:  

Year:  2015        PMID： 27134604      PMCID： PMC4849516     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  5 in total

Review 1.  Biologic agents for IBD: practical insights.

Authors:  Silvio Danese; Lucine Vuitton; Laurent Peyrin-Biroulet
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-08-18       Impact factor: 46.802

Review 2.  IBD pathogenesis in 2014: Molecular pathways controlling barrier function in IBD.

Authors:  Raja Atreya; Markus F Neurath
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-12-02       Impact factor: 46.802

Review 3.  Cytokines in inflammatory bowel disease.

Authors:  Markus F Neurath
Journal:  Nat Rev Immunol       Date:  2014-04-22       Impact factor: 53.106

Review 4.  Shared decision making in inflammatory bowel disease: helping patients understand the tradeoffs between treatment options.

Authors:  Corey A Siegel
Journal:  Gut       Date:  2011-12-20       Impact factor: 23.059

Review 5.  Mucosal healing as a target of therapy for colonic inflammatory bowel disease and methods to score disease activity.

Authors:  Alissa Walsh; Rebecca Palmer; Simon Travis
Journal:  Gastrointest Endosc Clin N Am       Date:  2014-05-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.